Drug Store News assembled a virtual roundtable of executives from generics companies to discuss the state of the industry and the challenges ahead, and how their companies plan to tackle them.
Jazz Pharmaceuticals' FDA approval of a new indication for Xyrem gives narcolepsy patients age seven years old and older a treatment for cataplexy, or excessive daytime sleepiness,
The National Association of Chain Drug Stores Foundation is collaborating with Project Lifeline to provide substance abuse screenings and referrals to at-risk patients in Pennsylvania.
Fresenius Kabi's arsenic trioxide injection is the first-to-market generic of Teva's Trisenox, which is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia.